- $18.99bn
- $20.16bn
- $15.80bn
- 73
- 90
- 68
- 91
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Other Revenue | |||||
Total Revenue | 9,526 | 9,735 | 12,846 | 11,675 | 15,804 |
Losses, Benefits, and Adjustments | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 7,066 | 8,461 | 9,605 | 11,769 | 12,875 |
Operating Profit | 2,460 | 1,273 | 3,242 | -93.3 | 2,929 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 2,286 | 1,000 | 3,130 | -152 | 2,654 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,799 | 832 | 2,446 | -103 | 2,101 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1,790 | 816 | 2,423 | -216 | 1,996 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,792 | 769 | 2,434 | -322 | 1,966 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 130 | 77.2 | 176 | -19.9 | 147 |